Health and Happiness (H&H) International Holdings ( (HK:1112) ) has issued an announcement.
Health and Happiness (H&H) International Holdings Limited reported a mid-single-digit decrease in total revenue for the year ended December 31, 2024, with strong growth in nutritional supplements offset by declines in the infant milk formula segment. Despite challenges, the company increased its market share in the super-premium infant milk formula segment in mainland China. The Adult Nutrition and Care segment saw high single-digit growth, driven by demand in core markets and innovative products, while the Baby Nutrition and Care segment faced a double-digit decline. The Pet Nutrition and Care segment achieved single-digit growth, with efforts focused on product portfolio premiumisation and channel optimisation. Financially, the company expects a mid-teens Adjusted EBITDA margin, although a decline of 10%-15% compared to the previous year is anticipated.
More about Health and Happiness (H&H) International Holdings
Health and Happiness (H&H) International Holdings Limited operates in the health and wellness industry, focusing on nutritional supplements, infant milk formulas, and pet nutrition. The company is known for its vitamin, herbal, and mineral supplements, as well as its presence in the super-premium infant milk formula segment, primarily targeting markets in mainland China, Australia, New Zealand, Southeast Asia, India, and the Middle East.
YTD Price Performance: 5.00%
Average Trading Volume: 101
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $734.2M
See more insights into 1112 stock on TipRanks’ Stock Analysis page.